This video is the second in a five-part series that focuses on making sense of multiple myeloma treatment based upon the newly obtained input from the American Society of Hematology (ASH) in Orlando, FL.

Download Slides

Topics include:

 


with an educational grant from:
Amgen Oncology, Takeda Oncology, Janssen Oncology

 

Previous Post
Significance of FiSH testing: IMWG Conference Series ASH 2019
Next Post
Smoldering Myeloma: IMWG Conference Series ASH 2019

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.